FDA rejects Adamis injection for treating acute allergies

March 27, 2015 10:35 PM

16 0

REUTERS: The United States Food and Drug Administration rejected Adamis Pharmaceuticals Corp's injection for treating severe allergic reactions, the company said.

Adamis Pharmaceuticals shares were down 37 percent at US$3.40 in after-market trading.

Read more

To category page